Effect of quercetin on inflammatory gene expression in mice liver in vivo - Role of redox factor 1, miRNA-122 and miRNA-125b

Pharmacological Research

Volumn 65, Issue 5, 2012, Pages 523-530

  Boesch Saadatmandi, Christine ^a,b   Wagner, Anika E ^a   Wolffram, Siegfried ^a   Rimbach, Gerald ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Gene expression; Inflammation; Micro RNA; Quercetin; Redox factor 1

Indexed keywords

ACYLOXYACYL HYDROLASE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; HYDROLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MICRORNA; MICRORNA 122; MICRORNA 125B; MONOCYTE CHEMOTACTIC PROTEIN 1; QUERCETIN; REDOX EFFECTOR FACTOR 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; GENE EXPRESSION REGULATION; GENETIC REGULATION; IN VIVO STUDY; INFLAMMATION; LIPID DIET; LIPID METABOLISM; LIVER; LIVER LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA ANALYSIS; SIGNAL TRANSDUCTION; STEADY STATE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; C-REACTIVE PROTEIN; CARBOXYLIC ESTER HYDROLASES; CHEMOKINE CCL2; DIETARY SUPPLEMENTS; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; FEMALE; GENE EXPRESSION REGULATION; HEPATITIS, ANIMAL; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LIPID METABOLISM; LIPIDS; LIVER; MICE; MICE, INBRED C57BL; MICRORNAS; OXIDATIVE STRESS; QUERCETIN; RNA, MESSENGER;

EID: 84859801133     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2012.02.007     Document Type: Article

References (51)

1. Manach C, Williamson G, Morand C, Scalbert A, Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. American Journal of Clinical Nutrition 2005;81:230S-42S.
2. Lotito SB, Frei B. Dietary flavonoids attenuate tumor necrosis factor alpha-induced adhesion molecule expression in human aortic endothelial cells. Structure-function relationships and activity after first pass metabolism. Journal of Biological Chemistry 2006;281:37102-10. (Pubitemid 46042180)
3. Nair MP, Mahajan S, Reynolds JL, Aalinkeel R, Nair H, Schwartz SA, et al. The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-kappa beta system. Clinical and Vaccine Immunology 2006;13:319-28.
4. Cho SY, Park SJ, Kwon MJ, Jeong TS, Bok SH, Choi WY, et al. Quercetin suppresses proinflammatory cytokines production through MAP kinases andNF-kappaB pathway in lipopolysaccharide-stimulated macrophage. Molecular and Cellular Biochemistry 2003;243:153-60.
5. Wadsworth TL, McDonald TL, Koop DR. Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced signaling pathways involved in the release of tumor necrosis factor-alpha. Biochemical Pharmacology 2001;62:963-74. (Pubitemid 32816982)
6. Jung WJ, Sung MK. Effects of major dietary antioxidants on inflammatory markers of RAW 264.7 macrophages. Biofactors 2004;21:113-7.
7. Boesch Saadatmandi C, Loboda A, Wagner A, Stachurska A, Jozkowicz A, Dulak J, et al. Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155. Journal of Nutritional Biochemistry 2011;22:293-9.
8. Egert S, Boesch-Saadatmandi C, Wolffram S, Rimbach G, Muller MJ. Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype. The Journal of Nutrition 2010;140:278-84.
9. Heinz SA, Henson DA, Nieman DC, Austin MD, Jin F. A 12-week supplementation with quercetin does not affect natural killer cell activity, granulocyte oxidative burst activity or granulocyte phagocytosis in female human subjects. The British Journal of Nutrition 2010;104:849-57.
10. Bae S-C, Jung W-J, Lee E-J, Yu R, Sung M-K. Effects of antioxidant supplements intervention on the level of plasma inflammatory molecules and disease severity of rheumatoid arthritis patients. Journal of the American College of Nutrition 2009;28:56-62.
11. Boots AW, Wilms LC, Swennen ELR, Kleinjans JCS, Bast A, Haenen GRMM. In vitro and ex vivo anti-inflammatory activity of quercetin in healthy volunteers. Nutrition (Burbank, Los Angeles County, Calif) 2008;24:703-10. (Pubitemid 351783378)
12. Sonkoly E, Pivarcsi A. microRNAs in inflammation. International Reviews of Immunology 2009;28:535-61.
13. Bieger J, Cermak R, Blank R, de Boer VC, Hollman PC, Kamphues J, et al. Tissue distribution of quercetin in pigs after long-term dietary supplementation. Journal of Nutrition 2008;138:1417-20.
14. Boesch-Saadatmandi C, Egert S, Schrader C, Coumol X, Barouki R, Muller MJ, et al. Effect of quercetin on paraoxonase 1 activity - studies in cultured cells, mice and humans. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 2010;61:99-105.
15. Rimbach G, Pallauf J. Phytic acid inhibits free radical formation in vitro but does not affect liver oxidant or antioxidant status in growing rats. Journal of Nutrition 1998;128:1950-5. (Pubitemid 28509860)
16. Hara A, Radin NS. Lipid extraction of tissues with a low-toxicity solvent. Analytical Biochemistry 1978;90:420-6. (Pubitemid 9062124)
17. Arkan MC, Hevener AL, Greten FR, Maeda S, Li Z-W, Long JM, et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nature Medicine 2005;11:191-8. (Pubitemid 40321355)
18. Liao F, Andalibi A, deBeer FC, Fogelman AM, Lusis AJ. Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice. Journal of Clinical Investigation 1993;91:2572-9. (Pubitemid 23182511)
19. Vergnes L, Phan J, Strauss M, Tafuri S, Reue K. Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression. The Journal of Biological Chemistry 2003;278:42774-84. (Pubitemid 37345887)
20. Kleemann R, Kooistra T. HMG-CoA reductase inhibitors: effects on chronic subacute inflammation and onset of atherosclerosis induced by dietary cholesterol. Current Drug Targets Cardiovascular & Haematological Disorders 2005;5:441-53. (Pubitemid 43012568)
21. Carlsen H, Haugen F, Zadelaar S, Kleemann R, Kooistra T, Drevon CA, et al. Diet-induced obesity increases NF-kappaB signaling in reporter mice. Genes & Nutrition 2009;4:215-22.
22. Chiang S-H, Bazuine M, Lumeng CN, Geletka LM, Mowers J, White NM, et al. The protein kinase IKKepsilon regulates energy balance in obese mice. Cell 2009;138:961-75.
23. Saliou C, Valacchi G, Rimbach G. Assessing bioflavonoids as regulators of NF-kappa B activity and inflammatory gene expression in mammalian cells. Methods in Enzymology 2001;335:380-7. (Pubitemid 32507255)
24. Kassel KM, Guo GL, Tawfik O, Luyendyk JP. Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet. Laboratory investigation; A Journal of Technical Methods and Pathology 2010;90:1794-804.
25. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K-i, Kitazawa R, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. The Journal of Clinical Investigation 2006;116:1494-505.
26. Rull A, Rodriguez F, Aragones G, Marsillach J, Beltran R, Alonso-Villaverde C, et al. Hepatic monocyte chemoattractant protein-1 is upregulated by dietary cholesterol and contributes to liver steatosis. Cytokine 2009;48:273-9.
27. Tous M, Ferre N, Rull A, Marsillach J, Coll B, Alonso-Villaverde C, et al. Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E-deficient mice. Biochemical and Biophysical Research Communications 2006;340:1078-84. (Pubitemid 43083388)
28. Marsillach J, Aragones G, Mackness B, Mackness M, Rull A, Beltran-Debon R, et al. Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment. Lipids in Health and Disease 2010;9:46.
29. Xanthoudakis S, Miao G, Wang F, Pan YC, Curran T. Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. The EMBO Journal 1992;11:3323-35.
30. Guan Z, Basi D, Li Q, Mariash A, Xia Y-F, Geng J-G, et al. Loss of redox factor 1 decreases NF-kappaB activity and increases susceptibility of endothelial cells to apoptosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2005;25:96-101. (Pubitemid 40054260)
31. Hall JL, Wang X, Van A, Zhao Y, Gibbons GH. Overexpression of Ref-1 inhibits hypoxia and tumor necrosis factor-induced endothelial cell apoptosis through nuclear factor-kappab-independent and -dependent pathways. Circulation Research 2001;88:1247-53. (Pubitemid 32587840)
32. Ding S-Z, O'Hara AM, Denning TL, Dirden-Kramer B, Mifflin RC, Reyes VE, et al. Helicobacter pylori and H2O2 increase AP endonuclease-1/redox factor-1 expression in human gastric epithelial cells. Gastroenterology 2004;127:845-58. (Pubitemid 39208417)
33. Flaherty DM, Monick MM, Carter AB, Peterson MW, Hunninghake GW. Oxidant-mediated increases in redox factor-1 nuclear protein and activator protein-1 DNA binding in asbestos-treated macrophages. Journal of Immunology (Baltimore, MD: 1950) 2002;168:5675-81.
34. Frossi B, Tell G, Spessotto P, Colombatti A, Vitale G, Pucillo C. H(2)O(2) induces translocation of APE/Ref-1 to mitochondria in the Raji B-cell line. Journal of Cellular Physiology 2002;193:180-6.
35. Grosch S, Fritz G, Kaina B. Apurinic endonuclease (Ref-1) is induced in mammalian cells by oxidative stress and involved in clastogenic adaptation. Cancer Research 1998;58:4410-6. (Pubitemid 28450044)
36. Ramana CV, Boldogh I, Izumi T, Mitra S. Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals. Proceedings of the National Academy of Sciences of the United States of America 1998;95:5061-6. (Pubitemid 28208550)
37. O'Hara AM, Bhattacharyya A, Bai J, Mifflin RC, Ernst PB, Mitra S, et al. Tumor necrosis factor (TNF)-alpha-induced IL-8 expression in gastric epithelial cells: role of reactive oxygen species and AP endonuclease-1/redox factor (Ref)-1. Cytokine 2009;46:359-69.
38. Kim JY, Jung KJ, Choi JS, Chung HY. Modulation of the age-related nuclear factorkappaB (NF-kappaB) pathway by hesperetin. Aging Cell 2006;5:401-11. (Pubitemid 44322536)
39. Tili E, Michaille J-J, Cimino A, Costinean S, Dumitru CD, Adair B, et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF- alpha stimulation and their possible roles in regulating the response to endotoxin shock. Journal of Immunology (Baltimore, MD: 1950) 2007;179:5082-9.
40. Sonkoly E, Wei T, Janson PCJ, Saaf A, Lundeberg L, Tengvall-Linder M, et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS ONE 2007;2:e610.
41. Gaedicke S, Zhang X, Schmelzer C, Lou Y, Doering F, Frank J, et al. Vitamin E dependent microRNA regulation in rat liver. FEBS Letters 2008;582:3542-6.
42. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metabolism 2006;3:87-98.
43. Girard M, Jacquemin E, Munnich A, Lyonnet S, Henrion-Caude A. miR-122, a paradigm for the role of microRNAs in the liver. Journal of Hepatology 2008;48:648-56.
44. Cheung O, Puri P, Eicken C, Contos MJ, Mirshahi F, Maher JW, et al. Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology 2008;48:1810-20.
45. Gatfield D, Le Martelot G, Vejnar CE, Gerlach D, Schaad O, Fleury-Olela F, et al. Integration of microRNA miR-122 in hepatic circadian gene expression. Genes and Development 2009;23:1313-26.
46. Barnes KC, Grant A, Gao P, Baltadjieva D, Berg T, Chi P, et al. Polymorphisms in the novel gene acyloxyacyl hydroxylase (AOAH) are associated with asthma and associated phenotypes. Journal of Allergy and Clinical Immunology 2006;118:70-7. (Pubitemid 43946475)
47. Shao B, Lu M, Katz SC, Varley AW, Hardwick J, Rogers TE, et al. A host lipase detoxifies bacterial lipopolysaccharides in the liver and spleen. The Journal of Biological Chemistry 2007;282:13726-35. (Pubitemid 47100530)
48. Matsumura T, Ito A, Takii T, Hayashi H, Onozaki K. Endotoxin and cytokine regulation of toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes. Journal of Interferon and Cytokine Research 2000;20:915-21.
49. Kim SJ, Choi Y, Choi YH, Park T. Obesity activates toll-like receptor-mediated proinflammatory signaling cascades in the adipose tissue of mice. The Journal of Nutritional Biochemistry 2012;23:113-22.
50. Harwood M, Danielewska-Nikiel B, Borzelleca JF, Flamm GW, Williams GM, Lines TC. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food and Chemical Toxicology 2007;45:2179-205. (Pubitemid 47451573)
51. Weldin J, Jack R, Dugaw K, Kapur RP. Quercetin, an over-the-counter supplement, causes neuroblastoma-like elevation of plasma homovanillic acid. Pediatric and Developmental Pathology 2003;6:547-51. (Pubitemid 38018670)